Piedmont’s institutional and
economic mission to Japan has focused on life sciences as part
of the week dedicated to the Region at Expo 2025 Osaka.
Piedmont’s delegation has visited Kobe as a guest of the
Foundation for Biomedical Research and Innovation.
It will also participate for the first time in Medical Japan in
Tokyo.
Meanwhile a round table has been held at the Italy Pavilion’s
auditorium, organized by bioPmed and Bioindustry Park.
The event was attended by the representatives of Piedmont’s and
Japan’s main clusters and the National Cluster of Life Sciences
Alisei.
The debate, moderated by Pietro Presti, a member of the
Scientific Committee of Bioindustry Park, placed at the centre
the common challenges in the biomedical and biotechnology
fields, highlighting the role of ecosystems of innovation as
engines of competitiveness and technological transfer.
During the meeting, the Memorandum of Understanding between
Osaka Bio Headquarters, bioPmed and Bioindustry Park was
presented.
The memorandum is aimed at promoting technological exchanges and
reciprocal access to life science markets.
Piedmont’s mission to Japan was promoted by the Piedmont Region
with Ceipiemonte, the Chamber of Commerce of Turin, bioPmed and
Bioindustry Park.
The initiative registered the participation of members of the
Kobe Biomedical Innovation Cluster, including Senior Coordinator
Takako Yokochi, and of representatives of Piedmont’s innovation
system, including Councillor Andrea Tronzano, the Director of
Ceipiemonte Stefano Nigro and the President of Bioindustry Park
Antonio Salvi.
“Life sciences are a strategic asset for Piedmont’s industrial
policy, with a supply chain integrating research, innovation and
productive capability”, stated Tronzano, stressing how “the
mission to Japan confirms the willingness to place Piedmont
within large global ecosystems, creating partnerships that
generate new opportunities for growth and technological
transfer”.
According to the president of Ceipiemonte, Dario Peirone,
“innovation, internationalization and the attraction of
investments are pillars of Piedmont’s strategy”.
The cooperation with Bioindustry Park and the participation in
Medical Japan, he added, “are fundamental tassels: we are
already achieving concrete results with new contacts and
opportunities of cooperation”.
On October 1-3, Piedmont will take part in Medical Japan, the
main Asian fair of the healthcare sector, with a group of six
companies that are part of the “Health and Well-being”
integrated project of the industry, coordinated by Ceipiemonte.
The presence will boost opportunities of cooperation between
Italian and Japanese companies in one of the world’s most
innovative markets.
ALL RIGHTS RESERVED © Copyright ANSA
AloJapan.com